For the year ending 2025-12-31, GOCO had -$8,017K decrease in cash & cash equivalents over the period. -$130,195K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | -497,755 |
| Share-based compensation | 9,170 |
| Depreciation and amortization | 9,564 |
| Amortization of intangible assets | 70,542 |
| Amortization of debt discount and issuance costs | 7,578 |
| Gain on bargain purchase | 0 |
| Loss on extinguishment of debt | -1,655 |
| Deferred tax liability | -3,762 |
| Non-cash lease expense | 2,976 |
| Other non-cash items, net | 346 |
| Accrued interest payable in kind | 39,327 |
| Indefinite and long-lived asset impairment charges | 259,961 |
| Accounts receivable | -4,379 |
| Commissions receivable | -128,447 |
| Prepaid expenses and other assets | -22,554 |
| Accounts payable | -7,667 |
| Accrued liabilities | -86,649 |
| Deferred revenue | -28,228 |
| Commissions payable | -55,949 |
| Operating lease liabilities | -2,894 |
| Other liabilities | 5,150 |
| Net cash provided by (used in) operating activities | -121,947 |
| Acquisition of business, net | 0 |
| Purchases of property, equipment and software | 8,248 |
| Net cash (used in) provided by investing activities | -8,248 |
| Proceeds from borrowings | 137,999 |
| Repayment of borrowings | 2,375 |
| Payment of debt discount and issuance costs | 8,408 |
| Repurchase of shares to satisfy employee tax withholding obligations | 5,221 |
| Proceeds from stock option exercises | 1 |
| Payment of preferred stock dividends | 0 |
| Net cash provided by (used in) financing activities | 121,996 |
| Effect of exchange rate changes on cash and cash equivalents | 182 |
| Increase (decrease) in cash and cash equivalents | -8,017 |
| Cash and cash equivalents at beginning of period | 40,921 |
| Cash and cash equivalents at end of period | 32,904 |
GoHealth, Inc. (GOCO)
GoHealth, Inc. (GOCO)